Related Experiment Video
Updated: Nov 20, 2025

13:35
Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
721
Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency
Naoki Horikoshi1,2,3, Sunhee Hwang4, Cornelius Gati2,3
1Life Science Center for Survival Dynamics, University of Tsukuba, Ibaraki 305-8577, Japan.
Summary
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common blood disorder, stems from mutations near the NADP+ site. These mutations disrupt enzyme function through a novel mechanism, offering new therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a prevalent blood disorder affecting 400 million globally, characterized by hemolytic anemia.
- Over 160 G6PD mutations exist, with 70 severe Class I mutations causing >90% enzyme activity loss.
- The molecular basis for Class I G6PD mutant dysfunction remains unclear, impeding therapeutic development.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying severe G6PD deficiency caused by Class I mutations.
- To investigate the structural and functional impact of mutations near the NADP+ binding site and dimer interface.
Main Methods:
- Integral structural characterization of five G6PD mutants (four Class I) using X-ray crystallography, SAXS, and cryo-EM.
- Biophysical analyses and molecular dynamics simulations were employed.
- Comparison with wild-type G6PD structure and properties.
Main Results:
- A universal mechanism for Class I G6PD deficiency was identified.
- Mutations near the noncatalytic NADP+ site destabilize dimer interface β-strands.
- This destabilization propagates to the active site via interconnected interactions.
Conclusions:
- The noncatalytic NADP+ binding site plays a critical role in stabilizing the G6PD dimer interface.
- Structural aberrations distant from the active site can be communicated to it, explaining severe G6PD deficiency.
- This provides a mechanistic basis for developing targeted therapies for G6PD deficiency.
Related Concept Videos
Inborn Errors of Metabolism
530
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
530
Lysosomal Hydrolases
4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Glucose Transporters
26.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.6K
Proteoglycans
4.3K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.3K
Pathophysiology of Diabetes
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K
Translation
153.1K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
153.1K

